The AATPAP sequence is a very efficient signal for O-glycosylation in CHO cells

被引:12
作者
Asada, M [1 ]
Orikasa, N [1 ]
Yoneda, A [1 ]
Oda, Y [1 ]
Ota, K [1 ]
Imamura, T [1 ]
机构
[1] Natl Inst Biosci & Human Technol, Biosignaling Dept, Tsukuba, Ibaraki 3058566, Japan
关键词
O-glycosylation signal; mucin; fibroblast growth factor; signal sequence;
D O I
10.1023/A:1007092708666
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The peptide signal sequence for protein O-glycosylation is not fully characterized, although a recent in vitro study proposed that the sequence motif, XTPXP, serves as a signal for mucin-type O-glycosylation. Here, we show that the AATPAP sequence acts as an efficient O-glycosylation signal, in vivo. A secreted fibroblast growth factor (secFGF) was used as a model to analyze glycosylation and its effects on the biological activity of FGF. Two constructs encoding [AATPAP]secFGF in which AATPAP was introduced at the N- or C-terminus of secFGF were constructed in a eukaryotic expression vector. [AATPAP]secFGF proteins were then expressed in Chinese hamster ovary (CHO) cells and secreted into the surrounding medium, primarily as modified forms sensitive to sialidase but not to peptide N-glycosidase F. The modifying groups were not seen when the AATPAP sequence was converted to AAAPAP or when [AATPAP]secFGF was expressed in mutant cells incapable of UDP-GalNAc biosynthesis. The results indicate that the modifying groups were mucin-type O-glycans and that the AATPAP served as an efficient O-glycosylation signal sequence. The O-glycosylated forms of [AATPAP]secFGF were as mitogenic toward human vascular endothelial cells as unmodified secFGF, suggesting that introduction of the signal into biologically active polypeptides is a promising approach with which O-glycosylation may be achieved without affecting original activity.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 21 条
[1]  
Aiyar A, 1996, Methods Mol Biol, V57, P177
[2]   Characterization of fibroblast growth factor-6 expressed by Chinese hamster ovary cells as a glycosylated mitogen for human vascular endothelial cells [J].
Asada, M ;
Yoneda, A ;
Oda, Y ;
Ota, K ;
Ozawa, K ;
Fukuta, K ;
Omae, F ;
Asanagi, M ;
Orikasa, N ;
Suzuki, M ;
Oka, S ;
Markino, T ;
Imamura, T .
GROWTH FACTORS, 1999, 16 (04) :293-303
[3]  
ELHAMMER AP, 1993, J BIOL CHEM, V268, P10029
[4]   O-GLYCBASE version 2.0: A revised database of O-glycosylated proteins [J].
Hansen, JE ;
Lund, O ;
Rapacki, K ;
Brunak, S .
NUCLEIC ACIDS RESEARCH, 1997, 25 (01) :278-282
[5]   NetOglyc: Prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility [J].
Hansen, JE ;
Lund, O ;
Tolstrup, N ;
Gooley, AA ;
Williams, KL ;
Brunak, S .
GLYCOCONJUGATE JOURNAL, 1998, 15 (02) :115-130
[6]   PREDICTION OF O-GLYCOSYLATION OF MAMMALIAN PROTEINS - SPECIFICITY PATTERNS OF UDP-GALNAC-POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE [J].
HANSEN, JE ;
LUND, O ;
ENGELBRECHT, J ;
BOHR, H ;
NIELSEN, JO ;
HANSEN, JES ;
BRUNAK, S .
BIOCHEMICAL JOURNAL, 1995, 308 :801-813
[7]   CELL CYCLE-DEPENDENT NUCLEAR-LOCALIZATION OF EXOGENOUSLY ADDED FIBROBLAST GROWTH-FACTOR-I IN BALB/C 3T3 AND HUMAN VASCULAR ENDOTHELIAL-CELLS [J].
IMAMURA, T ;
OKA, S ;
TANAHASHI, T ;
OKITA, Y .
EXPERIMENTAL CELL RESEARCH, 1994, 215 (02) :363-372
[8]   RECOVERY OF MITOGENIC ACTIVITY OF A GROWTH-FACTOR MUTANT WITH A NUCLEAR TRANSLOCATION SEQUENCE [J].
IMAMURA, T ;
ENGLEKA, K ;
ZHAN, X ;
TOKITA, Y ;
FOROUGH, R ;
ROEDER, D ;
JACKSON, A ;
MAIER, JAM ;
HLA, T ;
MACIAG, T .
SCIENCE, 1990, 249 (4976) :1567-1570
[9]   HEPARAN-SULFATE AND HEPARIN AS A POTENTIATOR OR A SUPPRESSOR OF GROWTH OF NORMAL AND TRANSFORMED VASCULAR ENDOTHELIAL-CELLS [J].
IMAMURA, T ;
MITSUI, Y .
EXPERIMENTAL CELL RESEARCH, 1987, 172 (01) :92-100
[10]   OLIGOSACCHARYL TRANSFERASE - THE CENTRAL ENZYME IN THE PATHWAY OF GLYCOPROTEIN ASSEMBLY [J].
KAPLAN, HA ;
WELPLY, JK ;
LENNARZ, WJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1987, 906 (02) :161-173